North America Radiopharmaceutical Theranostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Radiopharmaceutical Theranostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Radiopharmaceutical Theranostics Market Regional Analysis

6.2 North America Radiopharmaceutical Theranostics Market Revenue 2020-2028 (US$ Million)

6.3 North America Radiopharmaceutical Theranostics Market Forecast Analysis

7. North America Radiopharmaceutical Theranostics Market Analysis – by Product Type

7.1 Alpha Emitters

7.1.1 Overview
7.1.2 Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Beta Emitters

7.2.1 Overview
7.2.2 Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Positron Emission Tomography Tracers

7.3.1 Overview
7.3.2 Positron Emission Tomography Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1 Technetium-99

8.1.1 Overview
8.1.2 Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Gallium-68

8.2.1 Overview
8.2.2 Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Iodine-131

8.3.1 Overview
8.3.2 Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Iodine-123

8.4.1 Overview
8.4.2 Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Fluorine-18

8.5.1 Overview
8.5.2 Fluorine-18: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Yttrium 90

8.6.1 Overview
8.6.2 Yttrium 90: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.7 Lutetium 177

8.7.1 Overview
8.7.2 Lutetium 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.8 Copper 67

8.8.1 Overview
8.8.2 Copper 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.9 Copper 64

8.9.1 Overview
8.9.2 Copper 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Radiopharmaceutical Theranostics Market Analysis – by Source

9.1 Nuclear Reactors and Cyclotrons

9.1.1 Overview
9.1.2 Nuclear Reactors and Cyclotrons: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Radiopharmaceutical Theranostics Market Analysis – by Application

10.1 Targeted Therapeutic

10.1.1 Overview
10.1.2 Targeted Therapeutic: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Companion Diagnostic

10.2.1 Overview
10.2.2 Companion Diagnostic: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Radiopharmaceutical Theranostics Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Radiopharmaceutical Theranostics Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 North America Radiopharmaceutical Theranostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.1.2 US: North America Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.1.3 US: North America Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.1.4 US: North America Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.2 Canada: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.2.2 Canada: North America Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.2.3 Canada: North America Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.2.4 Canada: North America Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.3 Mexico : North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.3.2 Mexico : North America Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.3.3 Mexico : North America Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.3.4 Mexico : North America Radiopharmaceutical Theranostics Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bayer AG

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GE Healthcare Technologies Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Curium

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Lantheus Medical Imaging, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Telix Pharmaceuticals Ltd.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Cardinal Health Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Advanced Accelerator Applications S.A

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Jubilant Radiopharma

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Theragnostics

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 NuView Life Sciences

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Radiopharmaceutical Theranostics Market